Responding to Europe’s Declining Share of Global Innovation

João L. Carapinha, Ph.D.

Table of Contents

Poll 36 – 2026

2
Responding to Europe’s Declining Share of Global Innovation

I’ve been reflecting on how Europe’s shrinking role in pharmaceutical R&D and clinical trials is changing the evidence available for value assessment and shortening the window for premium pricing. If leaders want to protect timely, sustainable access, what should come first? Share your insights by voting below!

 

What should be the top priority to respond to the European Innovation Shift?

Table of Contents